CBP-1018 is a PDC (peptide drug conjugate) consisting of a dual targeting FRalpha/prostate-specific membrane antigen (PSMA) ligand (blue part) coupled to Monomethyl auristatin E (HY-15162) (red part) via a linker (HY-78738) (black part). CBP-1018 is expected to be used in breast cancer research[1].
Molecular Weight:
2839.18
CAS Number:
[2923068-30-6]
Formula:
C132H192N30O38S
Target:
Antifolate,Peptide-Drug Conjugates (PDCs)
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted